Surgery for Gastroesophageal Reflux Disease: Esophageal Impedance to Progress?

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 12, 2009, Pages 1264-1265

  Spechler, Stuart Jon ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR;

ANTIREFLUX OPERATION; EDITORIAL; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; REFLUX ESOPHAGITIS; STOMACH ACID SECRETION; STOMACH FUNDOPLICATION; STOMACH JUICE;

ELECTRIC IMPEDANCE; GASTROESOPHAGEAL REFLUX; HUMANS; TREATMENT OUTCOME;

EID: 70849100855     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.08.003     Document Type: Editorial

References (11)

1. Chiba N., De Gara C.J., Wilkinson J.M., et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 112 (1997) 1798-1810
2. Castell D.O., Kahrilas P.J., Richter J.E., et al. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol 97 (2002) 575-583
3. Nealis T.B., and Howden C.W. Is there a dark side to long-term proton pump inhibitor therapy?. Am J Ther 15 (2008) 536-542
4. Theisen J., Nehra D., Citron D., et al. Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg 4 (2000) 50-54
5. Lundell L., Miettinen P., Myrvold H.E., et al. Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis. Clin Gastroenterol Hepatol 7 (2009) 1292-1298
6. Tran T., Spechler S.J., Richardson P., et al. Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study. Am J Gastroenterol 100 (2005) 1002-1008
7. Peters M.J., Mukhtar A., Yunus R.M., et al. Meta-analysis of randomized clinical trials comparing open and laparoscopic anti-reflux surgery. Am J Gastroenterol 104 (2009) 1548-1561
8. Charbel S., Khandwala F., and Vaezi M.F. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol 100 (2005) 283-289
9. Spechler S.J., Sharma P., Traxler B., et al. Gastric and esophageal pH in patients with Barrett's esophagus treated with three omeprazole dosages: a randomized, double-blind, crossover trial. Am J Gastroenterol 101 (2006) 1964-1971
10. Mainie I., Tutuian R., Shay S., et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 55 (2006) 1398-1402
11. Mainie I., Tutuian R., Agrawal A., et al. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 93 (2006) 1483-1487